Nabaltec AG

  • WKN: A0KPPR
  • ISIN: DE000A0KPPR7
  • Land: Deutschland

Nachricht vom 28.10.2021 | 11:26

Nabaltec AG raises revenue forecast again for Financial Year 2021 and publishes preliminary quarterly data

DGAP-News: Nabaltec AG / Key word(s): 9 Month figures/Preliminary Results
28.10.2021 / 11:26
The issuer is solely responsible for the content of this announcement.

Nabaltec AG raises revenue forecast again for Financial Year 2021 and publishes preliminary quarterly data

Schwandorf, 28 October 2021 - Nabaltec is again increasing its revenue forecast for 2021, recently raised in July, due to the continued very positive business performance. For 2021 as a whole, Nabaltec AG now expects revenue growth in a range of 13% to 15% (previously: 11% to 14%). In addition, Nabaltec refined its EBIT margin for the current financial year, now expecting a range between 11% and 12% (previously: 10% to 12%).

According to preliminary data, consolidated revenue from January to September 2021 climbed to EUR 140.6 million, up 18.3% from the same period of last year (EUR 118.9 million). The "Functional Fillers" product segment achieved sales of EUR 97.7 million and the "Specialty Alumina" product segment of EUR 42.9 million, according to the preliminary data. In the third quarter of 2021, Nabaltec AG's revenue of EUR 46.7 million was 25.9% higher than in the same period from the previous year (EUR 37.1 million). According to the preliminary data, EBIT in the first nine months of 2021 was EUR 17.0 million, compared to EUR 5.0 million in the same period of last year. The EBIT margin (as a percentage of total performance) thus reached 12.3%.

Note: Nabaltec AG's quarterly report 3/2021 will be available for download as planned as of 25 November 2021 in the Investor Relations section of www.nabaltec.de/en.

 

About Nabaltec AG:
Nabaltec AG, with registered office in Schwandorf, a chemicals business which has received multiple awards for innovativeness, manufactures, develops and distributes highly specialized products based on aluminum hydroxide and aluminum oxide on an industrial scale through its two product segments, "Functional Fillers" and "Specialty Alumina." The company's product range includes eco-friendly flame retardant fillers and functional additives for the plastics industry. Flame retardant fillers are used e.g. in cables in tunnels, airports, high-rise buildings and electronic devices, while additives have applications in catalysis and in electric vehicles. Nabaltec also produces specialty oxides for use in technical ceramics, the refractory and polishing industries. Nabaltec maintains production sites in Germany and the US and plans to continue to develop its market position by expanding capacity, further optimizing processes and quality and making strategic extensions to its product range. On the strength of its specialty products, the company strives to attain the market leadership in each segment.

Contact:

Heidi Wiendl-Schneller Frank Ostermair/Vera Müller
Nabaltec AG Better Orange IR & HV AG
Phone: +49 9431 53-202 Phone: +49 89 8896906-14
Fax: +49 9431 53-260 Fax: +49 89 8896906-66
E-mail: InvestorRelations@nabaltec.de E-mail: nabaltec@better-orange.de


28.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021